UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Feb

    22

    Rare Disease Day 2024: The Moment is Now to Be Patient-First to Deliver for People Living with Rare Diseases

    Nov

    01

    UCB presents latest data from generalized myasthenia gravis portfolio at 2023 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) Scientific Session

    Sep

    12

    Disease Spotlight: Thymidine Kinase 2 Deficiency (TK2d)

    Jun

    01

    Myasthenia Gravis Awareness Month is the Time to Understand More About the Lived Experiences of the Community

    Mar

    31

    Employee Spotlight: Judith Thompson’s Journey to Making a Larger Impact through Addressing Health Disparities for People Living with Severe Diseases

    Feb

    17

    Patient-First, Patient-Focused: Our Purpose and Promise

    Jan

    13

    Patient-first: UCB is there to listen to patients, to not only learn more about them but also from them

    Jun

    01

    Life with MG & What I Wish For Everyone Who is Diagnosed

    Feb

    25

    Recognizing Rare Disease Day Every Day – The Importance of Addressing Unmet Patient Needs

    At UCB, we work 365-days-a-year to find new ways to deliver solutions, peace of mind, and opportunities to people living with severe diseases because everyone deserves to live the best life they can.

    Oct

    14

    UCB Unveils New Data on Living with Myasthenia Gravis at AANEM and MGFA Scientific Exhibit

    UCB’s ongoing work and unwavering focus keep people living with MG at the heart of everything we do, and we are committed to finding solutions for rare diseases, like MG, with a high degree of patient need by delivering purposeful innovations and differentiated solutions, creating value that cannot be expressed in numbers alone.